Cloverfields Capital Group, LP Novartis Ag Transaction History
Cloverfields Capital Group, LP
- $297 Million
- Q2 2025
A detailed history of Cloverfields Capital Group, LP transactions in Novartis Ag stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 20,495 shares of NVS stock, worth $2.68 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
20,495
Previous 19,295
6.22%
Holding current value
$2.68 Million
Previous $2.15 Million
15.3%
% of portfolio
0.83%
Previous 0.79%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,561Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.36 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.18 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$989 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$931 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $281B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...